Search for dissertations about: "diabetes and drug"
Showing result 1 - 5 of 151 swedish dissertations containing the words diabetes and drug.
-
1. Pharmacometrics Modelling in Type 2 Diabetes Mellitus : Implications on Study Design and Diabetes Disease Progression
Abstract : Pharmacometric modelling is widely used in many aspects related to type 2 diabetes mellitus (T2DM), for instance in the anti-diabetes drug development, and in quantifying the disease progression of T2DM.The aim of this thesis were to improve the design of early phase anti-diabetes drug development studies with the focus on the power to identify mechanism of drug action (MoA), and to characterize and quantify the progression from prediabetes to overt diabetes, both the natural progression and the progression with diet and exercise interventions, using pharmacometrics modelling. READ MORE
-
2. Behavioral effects of female sex steroid hormones : models of PMS and PMDD in Wistar rats
Abstract : Background Animal models can be used to mimic human conditions of psychopathology, and also as pre-clinical models to evaluate candidate drugs. With hormonal treatment it is possible to produce behavior in the rat which corresponds to the mental symptoms of pre-menstrual syndrome (PMS), and pre-menstrual dysphoric disorder (PMDD). READ MORE
-
3. Addison's disease and type 1 diabetes mellitus
Abstract : .... READ MORE
-
4. Epidemiological Aspects on Assessing and Treating Dyslipidemia in Type 1 Diabetes : Studies from the Swedish National Diabetes Register
Abstract : Background: Cardiovascular disease (CVD) is a major cause of shortened longevity in individuals with type 1 diabetes. Dyslipidemia is one of the important modifiable risk factors. Aims: To investigate different aspects of dyslipidemia in type 1 diabetes. READ MORE
-
5. Optimizing nicotinic acid delivery for durable antilipolysis and improved metabolic control
Abstract : Type 2 diabetes is a devastating disease affecting hundreds of millions worldwide. Lipid accumulation in peripheral non-adipose tissues is a major driver of insulin resistance, a central pathophysiological defect of this disease. READ MORE